JAMA Internal Medicine— The Year in Review, 2025 - Report - MDSpire

JAMA Internal Medicine— The Year in Review, 2025

  • By

  • Sharon K. Inouye

  • May 1, 2026

  • 0 min

Share

Clinical Report: Annual Overview of JAMA Internal Medicine, 2025

Overview

In 2025, JAMA Internal Medicine published 27 articles on women’s health and 46 clinical trial reports, reflecting its commitment to advancing medical knowledge. The journal achieved a 23.3 impact factor, solidifying its position as the leading internal medicine journal globally.

Background

The landscape of healthcare is rapidly evolving, necessitating rigorous scientific research to inform clinical practice and health policy. JAMA Internal Medicine plays a crucial role in disseminating high-quality research that addresses pressing public health issues, including health disparities and the care of vulnerable populations. The journal's focus on innovative studies, particularly in women's health and artificial intelligence, underscores its commitment to improving patient outcomes.

Data Highlights

MetricValue
Manuscripts Received4178
Acceptance Rate for Original Research4%
Overall Acceptance Rate12%
Median Time to First Decision (with Peer Review)35 days
Journal Impact Factor23.3
Weekly Digital Table Views330,000+
Article Views and Downloads21.8 million

Key Findings

  • Published 27 articles in response to the 2024 call for papers in Women’s Health.
  • Accepted 46 clinical trial reports in 2025, emphasizing rigorous scientific inquiry.
  • Achieved a journal impact factor of 23.3, ranking it as the top internal medicine journal worldwide.
  • More than 47% of submissions originated from outside the US, highlighting its global reach.
  • Top-viewed article focused on COVID-19 prevention with azelastine nasal spray.
  • Published 4 of the 5 top-cited articles across all internal medicine journals in 2025.

Clinical Implications

The findings from JAMA Internal Medicine underscore the importance of publishing high-quality, clinically relevant research that can directly influence patient care and health policy. Healthcare professionals should stay informed about the latest studies to enhance their practice and address emerging health challenges effectively.

Conclusion

JAMA Internal Medicine continues to be a pivotal resource for advancing internal medicine through its commitment to rigorous research and global collaboration. The journal's focus on impactful studies ensures that it remains at the forefront of medical knowledge dissemination.

References

  1. JAMA Internal Medicine, JAMA Internal Medicine, 2025 -- Annual Overview of JAMA Internal Medicine, 2025
  2. JAMA Internal Medicine, JAMA Internal Medicine Peer Reviewers in 2025 -- Peer Reviewers in 2025
  3. The Journal of Infectious Diseases, Looking Forward: The Journal of Infectious Diseases in 2025 -- Looking Forward: The Journal of Infectious Diseases in 2025
  4. JAMA Network Open, JAMA Network Open -- JAMA Network Open
  5. American Diabetes Association, The American Diabetes Association Releases “Standards of Care in Diabetes—2026” -- Standards of Care in Diabetes—2026
  6. JAMA Internal Medicine, Improving Empiric Antibiotic Selection for Patients Hospitalized With Skin and Soft Tissue Infection -- INSPIRE 3 Trial
  7. The American Diabetes Association Releases “Standards of Care in Diabetes—2026” | American Diabetes Association
  8. Improving Empiric Antibiotic Selection for Patients Hospitalized With Skin and Soft Tissue Infection: The INSPIRE 3 Skin and Soft Tissue Randomized Clinical Trial | Less is More | JAMA Internal Medicine | JAMA Network
  9. Anemia in CKD – KDIGO

Original Source(s)

Related Content